Operant Conditioning for Phantom Limb Pain
(OCS-PLP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The study will investigate the application of a non-pharmacological operant conditioning approach to reduce phantom limb pain (PLP). PLP afflicts 60-90% people who have lost a limb. It can last for years and lead to drug dependence, job loss, and poor quality of life. Current non-pharmacological interventions are encouraging but limited, and their efficacy remains unclear. Limb amputation is known to lead to abnormal sensorimotor reorganization in the brain. Multiple studies have shown that PLP severity is correlated with the extent of this reorganization. The current study will train participants via realtime feedback of brain responses to promote more normal sensorimotor response, with the goal to reduce phantom limb pain.
Will I have to stop taking my current medications?
The trial requires that you keep taking your current medications without any changes for at least 4 months from the start of the study.
Is operant conditioning therapy safe for humans?
How is Operant Conditioning with Peripheral Stimulation different from other treatments for phantom limb pain?
Operant Conditioning with Peripheral Stimulation is unique because it uses a learning-based approach to modify brain activity and reduce pain, unlike traditional treatments that focus on managing symptoms. This therapy involves actively engaging the brain's learning processes to change how pain is perceived, which can lead to long-term relief by reversing maladaptive brain changes associated with phantom limb pain.23456
What data supports the effectiveness of the treatment Operant Conditioning for Phantom Limb Pain?
Who Is on the Research Team?
Jodi A Brangaccio, PT
Principal Investigator
Albany VA Medical Center Samuel S. Stratton, Albany, NY
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've had an arm or leg amputated more than 6 months ago and suffer from moderate to severe phantom limb pain. They should be stable on current medications, if any, able to follow study instructions, and have medical clearance. Those with heart conditions, unstable health issues like uncontrolled diabetes, cognitive difficulties, skin disorders at the EEG site, or metal implants above the chest cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive peripheral stimulation with operant conditioning feedback training or without it, three 1-hour sessions per week
Follow-up
Participants are monitored for changes in somatosensory evoked potential and pain at 3 and 6 months after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Control Group with Peripheral Stimulation Only
- Operant Conditioning with Peripheral Stimulation
Operant Conditioning with Peripheral Stimulation is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor